Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways.

Huang T, Alvarez AA, Pangeni RP, Horbinski CM, Lu S, Kim SH, James CD, J Raizer J, A Kessler J, Brenann CW, Sulman EP, Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, Cheng SY.

Nat Commun. 2016 Oct 4;7:12885. doi: 10.1038/ncomms12885.

2.

miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.

Yang F, Liu X, Liu Y, Liu Y, Zhang C, Wang Z, Jiang T, Wang Y.

Cancer Lett. 2017 Jun 28;396:1-9. doi: 10.1016/j.canlet.2017.03.002. Epub 2017 Mar 9.

PMID:
28286260
3.

PI3 kinase pathway regulated miRNome in glioblastoma: identification of miR-326 as a tumour suppressor miRNA.

Nawaz Z, Patil V, Paul Y, Hegde AS, Arivazhagan A, Santosh V, Somasundaram K.

Mol Cancer. 2016 Nov 21;15(1):74.

4.

miR-577 inhibits glioblastoma tumor growth via the Wnt signaling pathway.

Zhang W, Shen C, Li C, Yang G, Liu H, Chen X, Zhu D, Zou H, Zhen Y, Zhang D, Zhao S.

Mol Carcinog. 2016 May;55(5):575-85. doi: 10.1002/mc.22304. Epub 2015 Mar 12.

PMID:
25764520
5.

A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.

Marziali G, Buccarelli M, Giuliani A, Ilari R, Grande S, Palma A, D'Alessandris QG, Martini M, Biffoni M, Pallini R, Ricci-Vitiani L.

Mol Oncol. 2017 Sep;11(9):1115-1129. doi: 10.1002/1878-0261.12047. Epub 2017 Jul 13.

6.

Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.

Lan F, Pan Q, Yu H, Yue X.

J Neurochem. 2015 Sep;134(5):811-8. doi: 10.1111/jnc.13174. Epub 2015 Jun 11.

7.

Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.

Sathyan P, Zinn PO, Marisetty AL, Liu B, Kamal MM, Singh SK, Bady P, Lu L, Wani KM, Veo BL, Gumin J, Kassem DH, Robinson F, Weng C, Baladandayuthapani V, Suki D, Colman H, Bhat KP, Sulman EP, Aldape K, Colen RR, Verhaak RG, Lu Z, Fuller GN, Huang S, Lang FF, Sawaya R, Hegi M, Majumder S.

J Neurosci. 2015 Nov 11;35(45):15097-112. doi: 10.1523/JNEUROSCI.1265-15.2015.

8.

miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.

Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Minn AJ, Simon MC.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):291-6. doi: 10.1073/pnas.1314341111. Epub 2013 Dec 24.

9.

Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.

Park EC, Kim G, Jung J, Wang K, Lee S, Jeon SS, Lee ZW, Kim SI, Kim S, Oh YT, Shin JH, Jang HS, Choi BO, Kim GH.

OMICS. 2013 May;17(5):259-68. doi: 10.1089/omi.2012.0065. Epub 2013 Apr 15.

PMID:
23586679
10.

MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.

Yang G, Han D, Chen X, Zhang D, Wang L, Shi C, Zhang W, Li C, Chen X, Liu H, Zhang D, Kang J, Peng F, Liu Z, Qi J, Gao X, Ai J, Shi C, Zhao S.

Neuro Oncol. 2014 May;16(5):652-61. doi: 10.1093/neuonc/not307. Epub 2014 Jan 23.

11.

miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.

Haemmig S, Baumgartner U, Glück A, Zbinden S, Tschan MP, Kappeler A, Mariani L, Vajtai I, Vassella E.

Cell Death Dis. 2014 Jun 5;5:e1279. doi: 10.1038/cddis.2014.245.

12.

MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.

Li D, Wang Z, Chen Z, Lin L, Wang Y, Sailike D, Luo K, Du G, Xiang X, Jiafu GD.

Biochem Biophys Res Commun. 2016 Dec 9;481(3-4):245-250. doi: 10.1016/j.bbrc.2016.10.132. Epub 2016 Nov 1.

PMID:
27815074
13.

miR-124 Acts as a Tumor Suppressor in Glioblastoma via the Inhibition of Signal Transducer and Activator of Transcription 3.

Li W, Huang H, Su J, Ji X, Zhang X, Zhang Z, Wang H.

Mol Neurobiol. 2017 May;54(4):2555-2561. doi: 10.1007/s12035-016-9852-z. Epub 2016 Mar 18. Retraction in: Mol Neurobiol. 2017 Dec;54(10 ):8461.

PMID:
26993295
14.

miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.

Lulli V, Buccarelli M, Martini M, Signore M, Biffoni M, Giannetti S, Morgante L, Marziali G, Ilari R, Pagliuca A, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L.

Oncotarget. 2015 Nov 10;6(35):37241-56. doi: 10.18632/oncotarget.5925.

15.

Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.

De Robertis A, Valensin S, Rossi M, Tunici P, Verani M, De Rosa A, Giordano C, Varrone M, Nencini A, Pratelli C, Benicchi T, Bakker A, Hill J, Sangthongpitag K, Pendharkar V, Liu B, Ng FM, Then SW, Jing Tai S, Cheong SM, He X, Caricasole A, Salerno M.

Mol Cancer Ther. 2013 Jul;12(7):1180-9. doi: 10.1158/1535-7163.MCT-12-1176-T. Epub 2013 Apr 25.

16.

MiR-519a functions as a tumor suppressor in glioma by targeting the oncogenic STAT3 pathway.

Hong L, Ya-Wei L, Hai W, Qiang Z, Jun-Jie L, Huang A, Song-Tao Q, Yun-Tao L.

J Neurooncol. 2016 May;128(1):35-45. doi: 10.1007/s11060-016-2095-z. Epub 2016 Mar 12.

PMID:
26970980
17.

Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, Lee Y, Joo KM, Lee J, Nam DH.

Neuro Oncol. 2013 Feb;15(2):161-71. doi: 10.1093/neuonc/nos299. Epub 2012 Dec 20.

18.

Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.

Jin X, Jeon HY, Joo KM, Kim JK, Jin J, Kim SH, Kang BG, Beck S, Lee SJ, Kim JK, Park AK, Park WY, Choi YJ, Nam DH, Kim H.

Cancer Res. 2011 Apr 15;71(8):3066-75. doi: 10.1158/0008-5472.CAN-10-1495. Epub 2011 Mar 1.

19.

PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.

Wang L, Liu J, Zhong Z, Gong X, Liu W, Shi L, Li X.

Brain Res. 2016 Sep 1;1646:441-450. doi: 10.1016/j.brainres.2016.06.026. Epub 2016 Jun 18.

PMID:
27328425
20.

Combination with TMZ and miR-505 inhibits the development of glioblastoma by regulating the WNT7B/Wnt/β-catenin signaling pathway.

Zhang C, Yang X, Fu C, Liu X.

Gene. 2018 Sep 25;672:172-179. doi: 10.1016/j.gene.2018.06.030. Epub 2018 Jun 12.

PMID:
29906532

Supplemental Content

Support Center